Danlu Wu

Danlu Wu is a Senior Scientist at Bio-Techne, specializing in immunoassay development and disease diagnosis. Prior roles include Clinical Assay Scientist at Meissa Vaccines, where they focused on developing intranasal vaccines for RSV and SARS-CoV-2, and Assay Development Scientist at Eutropics Pharmaceuticals, where they designed next-generation immunoassays for leukemia treatment. Danlu has also held positions at Tufts University and Multerra Bio, contributing to advancements in early-stage disease diagnostics and multiplexing assays. They are currently pursuing a Ph.D. in Analytical Chemistry, alongside a Master’s in Material Science and a Bachelor's in Polymer Chemistry from the University of Florida and the University of Science and Technology of China, respectively.